Sign in

CIK 0000315545

  • Non-accelerated filer
  • Smaller reporting company

PROVECTUS BIOPHARMACEUTICALS, INC.

Sign in to watch
Ticker
PVCT
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
900031917
Phone
+1 866-594-5999
Business address
800 S. GAY STREET, SUITE 1610, KNOXVILLE, TN, 37929
Former names
PROVECTUS PHARMACEUTICALS INC, PROVECTUS PHARMACEUTICAL INC, ZAMAGE DIGITAL IMAGING INC, SPM GROUP INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-06 Pershing Edward CEO Option exercise · 8% Unsecured Convertible Promissory Note −0
2026-11-06 Pershing Edward CEO Option exercise · Series D-1 Convertible Preferred Stock +13,216 3,043,893
2026-10-30 Pershing Edward CEO Option exercise · 8% Unsecured Convertible Promissory Note −0
2026-10-30 Pershing Edward CEO Option exercise · Series D-1 Convertible Preferred Stock +24,544 3,030,677
2026-10-23 Pershing Edward CEO Option exercise · 8% Unsecured Convertible Promissory Note −0
2026-10-23 Pershing Edward CEO Option exercise · Series D-1 Convertible Preferred Stock +7,599 3,006,133
2026-10-10 Pershing Edward CEO Option exercise · 8% Unsecured Convertible Promissory Note −0
2026-10-10 Pershing Edward CEO Option exercise · Series D-1 Convertible Preferred Stock +22,609 2,998,534
2026-10-03 Pershing Edward CEO Option exercise · 8% Unsecured Convertible Promissory Note −0
2026-10-03 Pershing Edward CEO Option exercise · Series D-1 Convertible Preferred Stock +13,216 2,975,925
2026-09-18 Pershing Edward CEO Option exercise · 8% Unsecured Convertible Promissory Note −0
2026-09-18 Pershing Edward CEO Option exercise · Series D-1 Convertible Preferred Stock +13,216 2,962,709
2026-09-11 Pershing Edward CEO Option exercise · 8% Unsecured Convertible Promissory Note −0
2026-09-11 Pershing Edward CEO Option exercise · Series D-1 Convertible Preferred Stock +13,216 2,949,493
2026-09-04 Pershing Edward CEO Option exercise · 8% Unsecured Convertible Promissory Note −0
2026-09-04 Pershing Edward CEO Option exercise · Series D-1 Convertible Preferred Stock +11,328 2,936,277
2026-08-26 Pershing Edward CEO Option exercise · 8% Unsecured Convertible Promissory Note −0
2026-08-26 Pershing Edward CEO Option exercise · Series D-1 Convertible Preferred Stock +11,328 2,924,949
2026-06-30 Pershing Edward CEO Grant or award · Series D-1 Convertible Preferred Stock +45,860 2,866,761
2026-06-30 Rodrigues Dominic PRESIDENT Grant or award · Series D-1 Convertible Preferred Stock +45,860 1,383,736

Page 1 of 17 · 329 trades